These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7671966)

  • 1. The role of polyols in the pathophysiology of hypergalactosemia.
    Berry GT
    Eur J Pediatr; 1995; 154(7 Suppl 2):S53-64. PubMed ID: 7671966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M; Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 May; 37(5):454-60. PubMed ID: 3285132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?
    Berry GT
    J Inherit Metab Dis; 2011 Apr; 34(2):345-55. PubMed ID: 21246399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent aspects of osmolyte changes in rat kidney, urine, blood and lens with sorbinil and galactose feeding.
    Edmands SD; Hughs KS; Lee SY; Meyer SD; Saari E; Yancey PH
    Kidney Int; 1995 Aug; 48(2):344-53. PubMed ID: 7564101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of sorbitol, galactitol, and myo-inositol in lens and sciatic nerve by high-performance liquid chromatography.
    Miwa I; Kanbara M; Wakazono H; Okuda J
    Anal Biochem; 1988 Aug; 173(1):39-44. PubMed ID: 3189800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback inhibition of aldose reductase gene expression in rat renal medulla. Galactitol accumulation reduces enzyme mRNA levels and depletes cellular inositol content.
    Bondy C; Cowley BD; Lightman SL; Kador PF
    J Clin Invest; 1990 Oct; 86(4):1103-8. PubMed ID: 2120282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of biochemical status in children with Duarte galactosemia: utility of galactose, galactitol, galactonate, and galactose 1-phosphate.
    Ficicioglu C; Hussa C; Gallagher PR; Thomas N; Yager C
    Clin Chem; 2010 Jul; 56(7):1177-82. PubMed ID: 20489133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 5. Mechanism of the myo-inositol efflux pathway.
    Reeves RE; Cammarata PR
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):619-29. PubMed ID: 8595962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
    Cammarata PR; Chen HQ
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes?
    Willars GB; Lambourne JE; Tomlinson DR
    Diabetes; 1987 Dec; 36(12):1425-31. PubMed ID: 3678622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A; Diecke FP; Mistry K; Ellison C; Cruz E
    Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control.
    Krabbi K; Uudelepp ML; Joost K; Zordania R; Õunap K
    Mol Genet Metab; 2011 Jul; 103(3):249-53. PubMed ID: 21501963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells.
    Yorek MA; Dunlap JA; Leeney EM
    Diabetes; 1989 Aug; 38(8):996-1004. PubMed ID: 2546844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma galactose and galactitol concentration in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia: determination by gas chromatography/mass spectrometry.
    Ning C; Segal S
    Metabolism; 2000 Nov; 49(11):1460-6. PubMed ID: 11092512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nerve structure and function in long-term galactosemic dogs: morphometric and electron microscopic analyses.
    Sugimoto K; Kasahara T; Yonezawa H; Yagihashi S
    Acta Neuropathol; 1999 Apr; 97(4):369-76. PubMed ID: 10208276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat.
    Meyer WR; Doyle MB; Grifo JA; Lipetz KJ; Oates PJ; DeCherney AH; Diamond MP
    Am J Obstet Gynecol; 1992 Dec; 167(6):1837-43. PubMed ID: 1471707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.